Hypofractionated stereotactic body radiation therapy as monotherapy for intermediate-risk prostate cancer

BACKGROUND: Hypofractionated stereotactic body radiation therapy (SBRT) has been advanced as monotherapy for low-risk prostate cancer. We examined the dose distributions and early clinical outcomes using this modality for the treatment of intermediate-risk prostate cancer. METHODS: Forty-one sequent...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Main Authors: Ju, Andrew W, Wang, Hongkun, Oermann, Eric K, Sherer, Benjamin A, Uhm, Sunghae, Chen, Viola J, Pendharkar, Arjun V, Hanscom, Heather N, Kim, Joy S, Lei, Siyuan, Suy, Simeng, Lynch, John H, Dritschilo, Anatoly, Collins, Sean P
Formato: Artigo
Idioma:Inglês
Publicado em: BioMed Central 2013
Assuntos:
Research
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC3570380/
https://ncbi.nlm.nih.gov/pubmed/23369294
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1186/1748-717X-8-30
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!

Registos relacionados